Cost-Effectiveness Analysis of Combined Chemotherapy Regimen Containing Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis in China
CONCLUSION: BR is shown to be cost effective. When the unit price of Bedaquiline reaches or falls below 57.21 yuan per unit, BR is expected to be the dominant strategy in China over CR.PMID:37424243 | DOI:10.3967/bes2023.061
Source: Biomedical and Environmental Sciences : BES - Category: Biomedical Science Authors: Cai Hong Xu Ying Peng Qiu Zi Long He Dong Mei Hu Xiao Yue Zhong Dan Chen Yuan Yuan Xu Yan Lin Zhao Source Type: research
More News: Bedaquiline | Biomedical Science | Chemotherapy | China Health | Environmental Health | Multidrug Resistance | Study | Tuberculosis